Neuromonitoring Devices Market By Component (Systems, Accessories (Stimulation Probe, Tubes, Electrodes, & Others) and Services); By Application (Neurosurgery, Spine Surgery, Vascular Surgery, Facial Nerve Surgery, Rectal Surgery, Colorectal Surgery, Brain Mapping, Thyroid Surgery, Ear, Nose and Throat (ENT) Surgery, and Others); By End User (Hospitals, Ambulatory Surgical Centres, and Others); By Distribution Channel (Direct and Indirect); By Region (North America (U.S., Canada, Mexico, & Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden & Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), & Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore & Rest of Southeast Asia), & Rest of Asia Pacific), Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, & Rest of Middle East & Africa) Latin America (Brazil, Argentina, & Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029
Industry Trends
The biggest driver for the growth of global neuromonitoring devices market is the need for better risk management during complex surgical procedures. Hence, the use of intraoperative neuromonitoring during a surgical procedure helps surgeons to reduce the risks of impairment to neurophysiological relevant nerve structures. It also prevents the possible impairment of nerve function which might happen due to improper positioning of the patient. High rates of neurological disorders due to various factors such as changes in the social environment, increased stress levels, and lifestyle changes is the second major factor creating demand and thus, advancing the growth of neuromonitoring devices market. Other factors supporting the market growth include increasing postoperative risks of cerebrovascular disorders and increased demand for automated neurological monitoring devices in hospitals. In July 2021, NuVasive received Conformité Européenne (CE) mark for Pulse platform. Global clinical evaluations started in many countries after that. The latest design update makes Pulse a platform to assist surgeons in all spine surgery-related procedures.
The shortage of professionals trained to operate neurological monitoring devices is the biggest restraint in the global neuromonitoring devices market growth. This problem is higher in developing countries, where technological knowhow is less. However, this may change in the future because of various companies spending heavily on the training of medical professionals and efforts of many governments to increase the role of technology in the field of medicine can boost the global neuromonitoring devices market in future.
Neuromonitoring is meant for a surgeon to evaluate the functioning of spinal cord when surgery is being performed on patient. Intraoperative neuromonitoring provides valuable information for a surgeon performing the complex spine surgery procedures and its main purpose is to prevent injury to a patient. Surgeons perform neuromonitoring via sequential dilation through the psoas muscle, passing each to the disk space. The electrophysiologic modalities employed by neuromonitoring include auditory brainstem response (ABR), extracellular single unit, local field recordings, and electromyography (EMG). For any surgery, modalities to be used depend on neural structures that are at risk. In February 2021, Rhythmlink received clearance from the U.S. Food & Drugs Administration (FDA) for new MR conditional electrode line called Sticky Pad Surface Electrodes. These peel and stick-on electrodes are useful for electroencephalography (EEG) and intraoperative neurophysiological monitoring (IONM).
For appropriate triage and treatment, time-sensitive neuromonitoring is essential in acute neurologic care settings. Neurologic manifestations of China-originated coronavirus disease in December 2019 infection include cerebrovascular events, intracranial hemorrhage, and seizures. Despite clinical neurologic examination remaining the acceptable standard for monitoring in the neurocritical care unit, late symptoms of neurologic complications can be the changes in the neurologic examination, especially when individuals are sedated. Due to technological advancement, devices offering multimodal monitoring in COVID-19 patients whose condition is critical, obtaining real-time detection of neurologic complications is possible, which enables prompt diagnosis and subsequent management. Common monitoring techniques used for detecting COVID-19 include EEG, near-infrared spectroscopy (NIRS), neuroimaging, optic nerve sheath diameter (ONSD), pupillometry, and transcranial doppler (TCD) ultrasonography. EEG is used for clinical events concerning for seizures, persistent encephalopathy, and poor recovery after discontinuing sedation. NIRS can be used for measuring cerebral oxygenation noninvasively. Hence, the need for coronavirus monitoring enabling effective treatment showcases substantial growth opportunities for global neuromonitoring devices market over the future years.
Technological advancement enabling the development of non-invasive devices and minimally invasive devices is anticipated to advance the growth of global neuromonitoring devices market over the forecast period. According to the U.S. Centers for Disease Control and Prevention (CDC), in the USA, about 4,600 adult day service centers offered long-term care services for assisted living and similar residential care communities in 2016. Same could be said for 4,300 hospice care facilities, 12,200 home health agencies, 15,600 nursing homes, and 28,900. Such facilities always need to buy neuromonitoring devices. Hence, along with such facilities the market for neuromonitoring devices useful for home care can also increase in the near future, creating new opportunities for sales in order to cater new demands.
In terms of revenue, neuromonitoring devices market was valued at US$ 7022.33 Mn in 2020 growing at a CAGR of 6.8% over the forecast period (2021 – 2029). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Neuromonitoring Devices Market Revenue & Forecast, (US$ Million), 2021 – 2029
Component Outlook:
In the context of component, the global neuromonitoring devices market has been primarily segmented into systems, accessories, and services. The accessories segment has been further segmented into stimulation probe, tubes, electrodes, and others.
The system segment accounted for the largest market share in the global neuromonitoring devices market in 2020 and during the forecast period, this segment is expected to achieving tremendous growth, primarily due to technological advancement. Devices like C2 NerveMonitor are capable of versatile use in operating room (OR). With intelligent technology, reliable signal stability can be ensured in the monitoring of motor and sensory nerves, along with an intuitive user interface that is simple to understand and easy to use. Most of the advanced systems help to create integrated patient database and universal serial bus (USB) interface for easy data export. Such devices enable efficient neuromonitoring at the time of performing facial nerve surgeries, neurosurgery, rectal surgeries, spinal surgeries, and vascular surgeries. In May 2021, Neurosign launched new intraoperative nerve monitor to preserve nerves. FDA cleared the V4 4-channel nerve monitoring system and 8-channel nerve monitoring system developed by Neurosign in March 2021.
Application Outlook:
Considering the application, global neuromonitoring devices market has been segmented into neurosurgery, spine surgery, vascular surgery, facial nerve surgery, rectal surgery, colorectal surgery, brain mapping, thyroid surgery, ear, nose and throat (ENT) surgery, and others.
The neurosurgery segment accounted for the largest market share in neuromonitoring devices market in 2020 due to extensive research and development (R&D) activities and improvements in the healthcare infrastructure. Specialized for cortical applications, devices like C2 Xtend are useful for advanced brain mapping for safe tumour resection in neurosurgery because in the resection of brain tumours, precision and safety are the biggest priorities. Devices like the NIM-Eclipse E4 system offer basic as well as advanced neuromonitoring capabilities such as intuitive display, and an easy user interface. Various technological advancements that include the development of innovative minimally invasive (MI) equipment is anticipated to further the segment’s growth over the future years. Such equipment include balloon catheters, flow diversion devices, liquid embolic & clot retrieval devices, and neuroendovascular stents.
End User Outlook:
On the basis of end users, the global neuromonitoring devices market has been segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment was the largest market segment in 2020. During the forecast period, ambulatory surgical centers (ASCs) segment is expected to witness highest growth rate. In majority situation, patients require emergency medical care and same-day surgical care that includes diagnostic services and preventive procedures. Growing investments towards enhancement of healthcare infrastructure is estimated to boost the segment’s growth over the future years.
Distribution Channel Outlook:
Based on distribution channel, the global neuromonitoring devices market has been segmented into direct distribution channel and indirect distribution channel. Direct distribution channel segment accounted for the largest market share in global neuromonitoring devices market in 2020. The large-scale establishments of hospitals and ASCs are increasingly considering to purchase directly from the manufacturer. However, during the forecast period, indirect distribution channel segment is expected to rise as the fastest growing market segment in the global neuromonitoring devices market.
Region Outlook:
North America accounted for a significant share in the global neuromonitoring devices market in 2020. However, during the forecast period, the Asia Pacific region is expected to become the fastest growing regional market due to rising incidences of several neurodegenerative disorders, increasing development of medical infrastructure in Asian countries such as Japan, Singapore, & South Korea and Governments of Asian countries like China & India encouraging research for technology that can ease medical treatments.
Competitive Landscape Outlook:
The report provides both, qualitative as well as quantitative research of global neuromonitoring devices market. It also provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as affiliations, collaborations, mergers & acquisitions (M&A), and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the neuromonitoring devices market are Cadwell Industries Inc., inomed Medizintechnik GmbH, Integra LifeSciences, Medtronic, Moberg Research Inc., Natus Medical, Neurosoft, Neurostyle, Neurovision Medical Products, and Nihon Kohden Corporation, amongst other market participants.
Global Neuromonitoring Devices Market:
By Component
- Systems
- Accessories
- Stimulation Probe
- Tubes
- Electrodes
- Others
- Services
By Application
- Neurosurgery
- Spine Surgery
- Vascular Surgery
- Facial Nerve Surgery
- Rectal Surgery
- Colorectal Surgery
- Brain Mapping
- Thyroid Surgery
- Ear, Nose and Throat (ENT) Surgery
- Others
By End User
- Hospitals
- Ambulatory Surgical Centres
- Others
By Distribution Channel
- Direct
- Indirect
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Market
Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2019
1.2.2. Base
Year: 2020
1.2.3. Forecast
Years: 2021 – 2029
2. Key Target
Audiences
3. Research
Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations
and Insights from AMI’s Perspective**
5. Holistic
Overview of Neuromonitoring Devices Market
6. Market
Synopsis: Neuromonitoring Devices Market
7. Neuromonitoring
Devices Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Neuromonitoring Devices Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Neuromonitoring Devices Market
7.6. Porter’s
Five Force Analysis
7.7. Impact of
Covid-19 on Neuromonitoring Devices Market
8. Global
Neuromonitoring Devices Market Analysis and Forecasts, 2021 – 2029
8.1. Overview
8.1.1. Global
Neuromonitoring Devices Market Revenue (US$ Mn)
8.2. Global
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Component
8.2.1. Systems
8.2.1.1. Definition
8.2.1.2. Market
Estimation and Penetration, 2015 - 2020
8.2.1.3. Market
Forecast, 2021 - 2029
8.2.1.4. Compound
Annual Growth Rate (CAGR)
8.2.1.5. Regional
Bifurcation
8.2.1.5.1. North
America
8.2.1.5.1.1. Market
Estimation, 2015 - 2020
8.2.1.5.1.2. Market
Forecast, 2021 - 2029
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 - 2020
8.2.1.5.2.2. Market
Forecast, 2021 - 2029
8.2.1.5.3. Asia
Pacific
8.2.1.5.3.1. Market
Estimation, 2015 - 2020
8.2.1.5.3.2. Market
Forecast, 2021 - 2029
8.2.1.5.4. Middle
East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 - 2020
8.2.1.5.4.2. Market
Forecast, 2021 - 2029
8.2.1.5.5. Latin
America
8.2.1.5.5.1. Market
Estimation, 2015 - 2020
8.2.1.5.5.2. Market
Forecast, 2021 - 2029
8.2.2. Accessories
(Definition, Market Estimation and Penetration, 2015 - 2020, Market Estimation
(2015 - 2020), Market Forecast (2021 - 2029), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Stimulation Probe, Tubes,
Electrodes, Others)
8.2.2.1. Stimulation
Probe
8.2.2.2. Tubes
8.2.2.3. Electrodes
8.2.2.4. Others
8.2.3. Services
8.2.3.1. Definition
8.2.3.2. Market
Estimation and Penetration, 2015 - 2020
8.2.3.3. Market
Forecast, 2021 - 2029
8.2.3.4. Compound
Annual Growth Rate (CAGR)
8.2.3.5. Regional
Bifurcation
8.2.3.5.1. North
America
8.2.3.5.1.1. Market
Estimation, 2015 - 2020
8.2.3.5.1.2. Market
Forecast, 2021 - 2029
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 - 2020
8.2.3.5.2.2. Market
Forecast, 2021 - 2029
8.2.3.5.3. Asia
Pacific
8.2.3.5.3.1. Market
Estimation, 2015 - 2020
8.2.3.5.3.2. Market
Forecast, 2021 - 2029
8.2.3.5.4. Middle
East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 - 2020
8.2.3.5.4.2. Market
Forecast, 2021 - 2029
8.2.3.5.5. Latin
America
8.2.3.5.5.1. Market
Estimation, 2015 - 2020
8.2.3.5.5.2. Market
Forecast, 2021 - 2029
8.3. Key
Segment for Channeling Investments
8.3.1. By
Component
9. Global
Neuromonitoring Devices Market Analysis and Forecasts, 2021 – 2029
9.1. Overview
9.2. Global
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Application
9.2.1. Neurosurgery
9.2.1.1. Definition
9.2.1.2. Market
Estimation and Penetration, 2015 - 2020
9.2.1.3. Market
Forecast, 2021 - 2029
9.2.1.4. Compound
Annual Growth Rate (CAGR)
9.2.1.5. Regional
Bifurcation
9.2.1.5.1. North
America
9.2.1.5.1.1. Market
Estimation, 2015 - 2020
9.2.1.5.1.2. Market
Forecast, 2021 - 2029
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2020
9.2.1.5.2.2. Market
Forecast, 2021 - 2029
9.2.1.5.3. Asia
Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2020
9.2.1.5.3.2. Market
Forecast, 2021 - 2029
9.2.1.5.4. Middle
East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2020
9.2.1.5.4.2. Market
Forecast, 2021 - 2029
9.2.1.5.5. Latin
America
9.2.1.5.5.1. Market
Estimation, 2015 - 2020
9.2.1.5.5.2. Market
Forecast, 2021 - 2029
9.2.2. Spine
Surgery
9.2.2.1. Definition
9.2.2.2. Market
Estimation and Penetration, 2015 - 2020
9.2.2.3. Market
Forecast, 2021 - 2029
9.2.2.4. Compound
Annual Growth Rate (CAGR)
9.2.2.5. Regional
Bifurcation
9.2.2.5.1. North
America
9.2.2.5.1.1. Market
Estimation, 2015 - 2020
9.2.2.5.1.2. Market
Forecast, 2021 - 2029
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2020
9.2.2.5.2.2. Market
Forecast, 2021 - 2029
9.2.2.5.3. Asia
Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2020
9.2.2.5.3.2. Market
Forecast, 2021 - 2029
9.2.2.5.4. Middle
East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2020
9.2.2.5.4.2. Market
Forecast, 2021 - 2029
9.2.2.5.5. Latin
America
9.2.2.5.5.1. Market
Estimation, 2015 - 2020
9.2.2.5.5.2. Market
Forecast, 2021 - 2029
9.2.3. Vascular
Surgery
9.2.3.1. Definition
9.2.3.2. Market
Estimation and Penetration, 2015 - 2020
9.2.3.3. Market
Forecast, 2021 - 2029
9.2.3.4. Compound
Annual Growth Rate (CAGR)
9.2.3.5. Regional
Bifurcation
9.2.3.5.1. North
America
9.2.3.5.1.1. Market
Estimation, 2015 - 2020
9.2.3.5.1.2. Market
Forecast, 2021 - 2029
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2020
9.2.3.5.2.2. Market
Forecast, 2021 - 2029
9.2.3.5.3. Asia
Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2020
9.2.3.5.3.2. Market
Forecast, 2021 - 2029
9.2.3.5.4. Middle
East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2020
9.2.3.5.4.2. Market
Forecast, 2021 - 2029
9.2.3.5.5. Latin
America
9.2.3.5.5.1. Market
Estimation, 2015 - 2020
9.2.3.5.5.2. Market
Forecast, 2021 - 2029
9.2.4. Facial
Nerve Surgery
9.2.4.1. Definition
9.2.4.2. Market
Estimation and Penetration, 2015 - 2020
9.2.4.3. Market
Forecast, 2021 - 2029
9.2.4.4. Compound
Annual Growth Rate (CAGR)
9.2.4.5. Regional
Bifurcation
9.2.4.5.1. North
America
9.2.4.5.1.1. Market
Estimation, 2015 - 2020
9.2.4.5.1.2. Market
Forecast, 2021 - 2029
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 - 2020
9.2.4.5.2.2. Market
Forecast, 2021 - 2029
9.2.4.5.3. Asia
Pacific
9.2.4.5.3.1. Market
Estimation, 2015 - 2020
9.2.4.5.3.2. Market
Forecast, 2021 - 2029
9.2.4.5.4. Middle
East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 - 2020
9.2.4.5.4.2. Market
Forecast, 2021 - 2029
9.2.4.5.5. Latin
America
9.2.4.5.5.1. Market
Estimation, 2015 - 2020
9.2.4.5.5.2. Market
Forecast, 2021 - 2029
9.2.5. Rectal
Surgery
9.2.5.1. Definition
9.2.5.2. Market
Estimation and Penetration, 2015 - 2020
9.2.5.3. Market
Forecast, 2021 - 2029
9.2.5.4. Compound
Annual Growth Rate (CAGR)
9.2.5.5. Regional
Bifurcation
9.2.5.5.1. North
America
9.2.5.5.1.1. Market
Estimation, 2015 - 2020
9.2.5.5.1.2. Market
Forecast, 2021 - 2029
9.2.5.5.2. Europe
9.2.5.5.2.1. Market
Estimation, 2015 - 2020
9.2.5.5.2.2. Market
Forecast, 2021 - 2029
9.2.5.5.3. Asia
Pacific
9.2.5.5.3.1. Market
Estimation, 2015 - 2020
9.2.5.5.3.2. Market
Forecast, 2021 - 2029
9.2.5.5.4. Middle
East and Africa
9.2.5.5.4.1. Market
Estimation, 2015 - 2020
9.2.5.5.4.2. Market
Forecast, 2021 - 2029
9.2.5.5.5. Latin
America
9.2.5.5.5.1. Market
Estimation, 2015 - 2020
9.2.5.5.5.2. Market
Forecast, 2021 - 2029
9.2.6. Colorectal
Surgery
9.2.6.1. Definition
9.2.6.2. Market
Estimation and Penetration, 2015 - 2020
9.2.6.3. Market
Forecast, 2021 - 2029
9.2.6.4. Compound
Annual Growth Rate (CAGR)
9.2.6.5. Regional
Bifurcation
9.2.6.5.1. North
America
9.2.6.5.1.1. Market
Estimation, 2015 - 2020
9.2.6.5.1.2. Market
Forecast, 2021 - 2029
9.2.6.5.2. Europe
9.2.6.5.2.1. Market
Estimation, 2015 - 2020
9.2.6.5.2.2. Market
Forecast, 2021 - 2029
9.2.6.5.3. Asia
Pacific
9.2.6.5.3.1. Market
Estimation, 2015 - 2020
9.2.6.5.3.2. Market
Forecast, 2021 - 2029
9.2.6.5.4. Middle
East and Africa
9.2.6.5.4.1. Market
Estimation, 2015 - 2020
9.2.6.5.4.2. Market
Forecast, 2021 - 2029
9.2.6.5.5. Latin
America
9.2.6.5.5.1. Market
Estimation, 2015 - 2020
9.2.6.5.5.2. Market
Forecast, 2021 - 2029
9.2.7. Brain
Mapping
9.2.7.1. Definition
9.2.7.2. Market
Estimation and Penetration, 2015 - 2020
9.2.7.3. Market
Forecast, 2021 - 2029
9.2.7.4. Compound
Annual Growth Rate (CAGR)
9.2.7.5. Regional
Bifurcation
9.2.7.5.1. North
America
9.2.7.5.1.1. Market
Estimation, 2015 - 2020
9.2.7.5.1.2. Market
Forecast, 2021 - 2029
9.2.7.5.2. Europe
9.2.7.5.2.1. Market
Estimation, 2015 - 2020
9.2.7.5.2.2. Market
Forecast, 2021 - 2029
9.2.7.5.3. Asia
Pacific
9.2.7.5.3.1. Market
Estimation, 2015 - 2020
9.2.7.5.3.2. Market
Forecast, 2021 - 2029
9.2.7.5.4. Middle
East and Africa
9.2.7.5.4.1. Market
Estimation, 2015 - 2020
9.2.7.5.4.2. Market
Forecast, 2021 - 2029
9.2.7.5.5. Latin
America
9.2.7.5.5.1. Market
Estimation, 2015 - 2020
9.2.7.5.5.2. Market
Forecast, 2021 - 2029
9.2.8. Thyroid
Surgery
9.2.8.1. Definition
9.2.8.2. Market
Estimation and Penetration, 2015 - 2020
9.2.8.3. Market
Forecast, 2021 - 2029
9.2.8.4. Compound
Annual Growth Rate (CAGR)
9.2.8.5. Regional
Bifurcation
9.2.8.5.1. North
America
9.2.8.5.1.1. Market
Estimation, 2015 - 2020
9.2.8.5.1.2. Market
Forecast, 2021 - 2029
9.2.8.5.2. Europe
9.2.8.5.2.1. Market
Estimation, 2015 - 2020
9.2.8.5.2.2. Market
Forecast, 2021 - 2029
9.2.8.5.3. Asia
Pacific
9.2.8.5.3.1. Market
Estimation, 2015 - 2020
9.2.8.5.3.2. Market
Forecast, 2021 - 2029
9.2.8.5.4. Middle
East and Africa
9.2.8.5.4.1. Market
Estimation, 2015 - 2020
9.2.8.5.4.2. Market
Forecast, 2021 - 2029
9.2.8.5.5. Latin
America
9.2.8.5.5.1. Market
Estimation, 2015 - 2020
9.2.8.5.5.2. Market
Forecast, 2021 - 2029
9.2.9. Ear,
Nose and Throat (ENT) Surgery
9.2.9.1. Definition
9.2.9.2. Market
Estimation and Penetration, 2015 - 2020
9.2.9.3. Market
Forecast, 2021 - 2029
9.2.9.4. Compound
Annual Growth Rate (CAGR)
9.2.9.5. Regional
Bifurcation
9.2.9.5.1. North
America
9.2.9.5.1.1. Market
Estimation, 2015 - 2020
9.2.9.5.1.2. Market
Forecast, 2021 - 2029
9.2.9.5.2. Europe
9.2.9.5.2.1. Market
Estimation, 2015 - 2020
9.2.9.5.2.2. Market
Forecast, 2021 - 2029
9.2.9.5.3. Asia
Pacific
9.2.9.5.3.1. Market
Estimation, 2015 - 2020
9.2.9.5.3.2. Market
Forecast, 2021 - 2029
9.2.9.5.4. Middle
East and Africa
9.2.9.5.4.1. Market
Estimation, 2015 - 2020
9.2.9.5.4.2. Market
Forecast, 2021 - 2029
9.2.9.5.5. Latin
America
9.2.9.5.5.1. Market
Estimation, 2015 - 2020
9.2.9.5.5.2. Market
Forecast, 2021 - 2029
9.2.10. Others
9.2.10.1. Definition
9.2.10.2. Market
Estimation and Penetration, 2015 - 2020
9.2.10.3. Market
Forecast, 2021 - 2029
9.2.10.4. Compound
Annual Growth Rate (CAGR)
9.2.10.5. Regional
Bifurcation
9.2.10.5.1. North
America
9.2.10.5.1.1. Market
Estimation, 2015 - 2020
9.2.10.5.1.2. Market
Forecast, 2021 - 2029
9.2.10.5.2. Europe
9.2.10.5.2.1. Market
Estimation, 2015 - 2020
9.2.10.5.2.2. Market
Forecast, 2021 - 2029
9.2.10.5.3. Asia
Pacific
9.2.10.5.3.1. Market
Estimation, 2015 - 2020
9.2.10.5.3.2. Market
Forecast, 2021 - 2029
9.2.10.5.4. Middle
East and Africa
9.2.10.5.4.1. Market
Estimation, 2015 - 2020
9.2.10.5.4.2. Market
Forecast, 2021 - 2029
9.2.10.5.5. Latin
America
9.2.10.5.5.1. Market
Estimation, 2015 - 2020
9.2.10.5.5.2. Market
Forecast, 2021 - 2029
9.3. Key
Segment for Channeling Investments
9.3.1. By
Application
10. Global
Neuromonitoring Devices Market Analysis and Forecasts, 2021 – 2029
10.1. Overview
10.2. Global
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By End-User
10.2.1. Hospitals
10.2.1.1. Definition
10.2.1.2. Market
Estimation and Penetration, 2015 - 2020
10.2.1.3. Market
Forecast, 2021 - 2029
10.2.1.4. Compound
Annual Growth Rate (CAGR)
10.2.1.5. Regional
Bifurcation
10.2.1.5.1. North
America
10.2.1.5.1.1. Market
Estimation, 2015 - 2020
10.2.1.5.1.2. Market
Forecast, 2021 - 2029
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 - 2020
10.2.1.5.2.2. Market
Forecast, 2021 - 2029
10.2.1.5.3. Asia
Pacific
10.2.1.5.3.1. Market
Estimation, 2015 - 2020
10.2.1.5.3.2. Market
Forecast, 2021 - 2029
10.2.1.5.4. Middle
East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 - 2020
10.2.1.5.4.2. Market
Forecast, 2021 - 2029
10.2.1.5.5. Latin
America
10.2.1.5.5.1. Market
Estimation, 2015 - 2020
10.2.1.5.5.2. Market
Forecast, 2021 - 2029
10.2.2. Ambulatory
Surgical Centers
10.2.2.1. Definition
10.2.2.2. Market
Estimation and Penetration, 2015 - 2020
10.2.2.3. Market
Forecast, 2021 - 2029
10.2.2.4. Compound
Annual Growth Rate (CAGR)
10.2.2.5. Regional
Bifurcation
10.2.2.5.1. North
America
10.2.2.5.1.1. Market
Estimation, 2015 - 2020
10.2.2.5.1.2. Market
Forecast, 2021 - 2029
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2020
10.2.2.5.2.2. Market
Forecast, 2021 - 2029
10.2.2.5.3. Asia
Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2020
10.2.2.5.3.2. Market
Forecast, 2021 - 2029
10.2.2.5.4. Middle
East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2020
10.2.2.5.4.2. Market
Forecast, 2021 - 2029
10.2.2.5.5. Latin
America
10.2.2.5.5.1. Market
Estimation, 2015 - 2020
10.2.2.5.5.2. Market
Forecast, 2021 - 2029
10.2.3. Others
10.2.3.1. Definition
10.2.3.2. Market
Estimation and Penetration, 2015 - 2020
10.2.3.3. Market
Forecast, 2021 - 2029
10.2.3.4. Compound
Annual Growth Rate (CAGR)
10.2.3.5. Regional
Bifurcation
10.2.3.5.1. North
America
10.2.3.5.1.1. Market
Estimation, 2015 - 2020
10.2.3.5.1.2. Market
Forecast, 2021 - 2029
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 - 2020
10.2.3.5.2.2. Market
Forecast, 2021 - 2029
10.2.3.5.3. Asia
Pacific
10.2.3.5.3.1. Market
Estimation, 2015 - 2020
10.2.3.5.3.2. Market
Forecast, 2021 - 2029
10.2.3.5.4. Middle
East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 - 2020
10.2.3.5.4.2. Market
Forecast, 2021 - 2029
10.2.3.5.5. Latin
America
10.2.3.5.5.1. Market
Estimation, 2015 - 2020
10.2.3.5.5.2. Market
Forecast, 2021 - 2029
10.3. Key
Segment for Channeling Investments
10.3.1. By
End-User
11. Global
Neuromonitoring Devices Market Analysis and Forecasts, 2021 – 2029
11.1. Overview
11.2. Global
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
11.2.1. Direct
11.2.1.1. Definition
11.2.1.2. Market
Estimation and Penetration, 2015 - 2020
11.2.1.3. Market
Forecast, 2021 - 2029
11.2.1.4. Compound
Annual Growth Rate (CAGR)
11.2.1.5. Regional
Bifurcation
11.2.1.5.1. North
America
11.2.1.5.1.1. Market
Estimation, 2015 - 2020
11.2.1.5.1.2. Market
Forecast, 2021 - 2029
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 - 2020
11.2.1.5.2.2. Market
Forecast, 2021 - 2029
11.2.1.5.3. Asia
Pacific
11.2.1.5.3.1. Market
Estimation, 2015 - 2020
11.2.1.5.3.2. Market
Forecast, 2021 - 2029
11.2.1.5.4. Middle
East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 - 2020
11.2.1.5.4.2. Market
Forecast, 2021 - 2029
11.2.1.5.5. Latin
America
11.2.1.5.5.1. Market
Estimation, 2015 - 2020
11.2.1.5.5.2. Market
Forecast, 2021 - 2029
11.2.2. Indirect
11.2.2.1. Definition
11.2.2.2. Market
Estimation and Penetration, 2015 - 2020
11.2.2.3. Market
Forecast, 2021 - 2029
11.2.2.4. Compound
Annual Growth Rate (CAGR)
11.2.2.5. Regional
Bifurcation
11.2.2.5.1. North
America
11.2.2.5.1.1. Market
Estimation, 2015 - 2020
11.2.2.5.1.2. Market
Forecast, 2021 - 2029
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 - 2020
11.2.2.5.2.2. Market
Forecast, 2021 - 2029
11.2.2.5.3. Asia
Pacific
11.2.2.5.3.1. Market
Estimation, 2015 - 2020
11.2.2.5.3.2. Market
Forecast, 2021 - 2029
11.2.2.5.4. Middle
East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 - 2020
11.2.2.5.4.2. Market
Forecast, 2021 - 2029
11.2.2.5.5. Latin
America
11.2.2.5.5.1. Market
Estimation, 2015 - 2020
11.2.2.5.5.2. Market
Forecast, 2021 - 2029
11.3. Key
Segment for Channeling Investments
11.3.1. By
Distribution Channel
12. North
America Neuromonitoring Devices Market Analysis and Forecasts, 2021 - 2029
12.1. Overview
12.1.1. North
America Neuromonitoring Devices Market Revenue (US$ Mn)
12.2. North
America Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Component
12.2.1. Systems
12.2.2. Accessories
12.2.2.1. Stimulation
Probe
12.2.2.2. Tubes
12.2.2.3. Electrodes
12.2.2.4. Others
12.2.3. Services
12.3. North
America Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Application
12.3.1. Neurosurgery
12.3.2. Spine
Surgery
12.3.3. Vascular
Surgery
12.3.4. Facial
Nerve Surgery
12.3.5. Rectal
Surgery
12.3.6. Colorectal
Surgery
12.3.7. Brain
Mapping
12.3.8. Thyroid
Surgery
12.3.9. Ear,
Nose and Throat (ENT) Surgery
12.3.10. Others
12.4. North
America Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
End-User
12.4.1. Hospitals
12.4.2. Ambulatory
Surgical Centers
12.4.3. Others
12.5. North
America Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
12.5.1. Direct
12.5.2. Indirect
12.6. North
America Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Country
12.6.1. U.S
12.6.1.1. U.S
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Component
12.6.1.1.1. Systems
12.6.1.1.2. Accessories
12.6.1.1.2.1. Stimulation
Probe
12.6.1.1.2.2. Tubes
12.6.1.1.2.3. Electrodes
12.6.1.1.2.4. Others
12.6.1.1.3. Services
12.6.1.2. U.S
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Application
12.6.1.2.1. Neurosurgery
12.6.1.2.2. Spine
Surgery
12.6.1.2.3. Vascular
Surgery
12.6.1.2.4. Facial
Nerve Surgery
12.6.1.2.5. Rectal
Surgery
12.6.1.2.6. Colorectal
Surgery
12.6.1.2.7. Brain
Mapping
12.6.1.2.8. Thyroid
Surgery
12.6.1.2.9. Ear,
Nose and Throat (ENT) Surgery
12.6.1.2.10. Others
12.6.1.3. U.S
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By End-User
12.6.1.3.1. Hospitals
12.6.1.3.2. Ambulatory
Surgical Centers
12.6.1.3.3. Others
12.6.1.4. U.S
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
12.6.1.4.1. Direct
12.6.1.4.2. Indirect
12.6.2. Canada
12.6.2.1. Canada
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Component
12.6.2.1.1. Systems
12.6.2.1.2. Accessories
12.6.2.1.2.1. Stimulation
Probe
12.6.2.1.2.2. Tubes
12.6.2.1.2.3. Electrodes
12.6.2.1.2.4. Others
12.6.2.1.3. Services
12.6.2.2. Canada
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Application
12.6.2.2.1. Neurosurgery
12.6.2.2.2. Spine
Surgery
12.6.2.2.3. Vascular
Surgery
12.6.2.2.4. Facial
Nerve Surgery
12.6.2.2.5. Rectal
Surgery
12.6.2.2.6. Colorectal
Surgery
12.6.2.2.7. Brain
Mapping
12.6.2.2.8. Thyroid
Surgery
12.6.2.2.9. Ear,
Nose and Throat (ENT) Surgery
12.6.2.2.10. Others
12.6.2.3. Canada
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By End-User
12.6.2.3.1. Hospitals
12.6.2.3.2. Ambulatory
Surgical Centers
12.6.2.3.3. Others
12.6.2.4. Canada
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
12.6.2.4.1. Direct
12.6.2.4.2. Indirect
12.6.3. Mexico
12.6.3.1. Mexico
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Component
12.6.3.1.1. Systems
12.6.3.1.2. Accessories
12.6.3.1.2.1. Stimulation
Probe
12.6.3.1.2.2. Tubes
12.6.3.1.2.3. Electrodes
12.6.3.1.2.4. Others
12.6.3.1.3. Services
12.6.3.2. Mexico
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Application
12.6.3.2.1. Neurosurgery
12.6.3.2.2. Spine
Surgery
12.6.3.2.3. Vascular
Surgery
12.6.3.2.4. Facial
Nerve Surgery
12.6.3.2.5. Rectal
Surgery
12.6.3.2.6. Colorectal
Surgery
12.6.3.2.7. Brain
Mapping
12.6.3.2.8. Thyroid
Surgery
12.6.3.2.9. Ear,
Nose and Throat (ENT) Surgery
12.6.3.2.10. Others
12.6.3.3. Mexico
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By End-User
12.6.3.3.1. Hospitals
12.6.3.3.2. Ambulatory
Surgical Centers
12.6.3.3.3. Others
12.6.3.4. Mexico
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
12.6.3.4.1. Direct
12.6.3.4.2. Indirect
12.6.4. Rest of
North America
12.6.4.1. Rest
of North America Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts,
By Component
12.6.4.1.1. Systems
12.6.4.1.2. Accessories
12.6.4.1.2.1. Stimulation
Probe
12.6.4.1.2.2. Tubes
12.6.4.1.2.3. Electrodes
12.6.4.1.2.4. Others
12.6.4.1.3. Services
12.6.4.2. Rest
of North America Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts,
By Application
12.6.4.2.1. Neurosurgery
12.6.4.2.2. Spine
Surgery
12.6.4.2.3. Vascular
Surgery
12.6.4.2.4. Facial
Nerve Surgery
12.6.4.2.5. Rectal
Surgery
12.6.4.2.6. Colorectal
Surgery
12.6.4.2.7. Brain
Mapping
12.6.4.2.8. Thyroid
Surgery
12.6.4.2.9. Ear,
Nose and Throat (ENT) Surgery
12.6.4.2.10. Others
12.6.4.3. Rest
of North America Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts,
By End-User
12.6.4.3.1. Hospitals
12.6.4.3.2. Ambulatory
Surgical Centers
12.6.4.3.3. Others
12.6.4.4. Rest
of North America Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
12.6.4.4.1. Direct
12.6.4.4.2. Indirect
12.7. Key
Segment for Channeling Investments
12.7.1. By
Country
12.7.2. By
Component
12.7.3. By
Application
12.7.4. By
End-User
12.7.5. By
Distribution Channel
13. Europe
Neuromonitoring Devices Market Analysis and Forecasts, 2021 - 2029
13.1. Overview
13.1.1. Europe
Neuromonitoring Devices Market Revenue (US$ Mn)
13.2. Europe
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Component
13.2.1. Systems
13.2.2. Accessories
13.2.2.1. Stimulation
Probe
13.2.2.2. Tubes
13.2.2.3. Electrodes
13.2.2.4. Others
13.2.3. Services
13.3. Europe
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Application
13.3.1. Neurosurgery
13.3.2. Spine
Surgery
13.3.3. Vascular
Surgery
13.3.4. Facial
Nerve Surgery
13.3.5. Rectal
Surgery
13.3.6. Colorectal
Surgery
13.3.7. Brain
Mapping
13.3.8. Thyroid
Surgery
13.3.9. Ear,
Nose and Throat (ENT) Surgery
13.3.10. Others
13.4. Europe
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By End-User
13.4.1. Hospitals
13.4.2. Ambulatory
Surgical Centers
13.4.3. Others
13.5. Europe
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
13.5.1. Direct
13.5.2. Indirect
13.6. Europe
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Country
13.6.1. France
13.6.1.1. France
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Component
13.6.1.1.1. Systems
13.6.1.1.2. Accessories
13.6.1.1.2.1. Stimulation
Probe
13.6.1.1.2.2. Tubes
13.6.1.1.2.3. Electrodes
13.6.1.1.2.4. Others
13.6.1.1.3. Services
13.6.1.2. France
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Application
13.6.1.2.1. Neurosurgery
13.6.1.2.2. Spine
Surgery
13.6.1.2.3. Vascular
Surgery
13.6.1.2.4. Facial
Nerve Surgery
13.6.1.2.5. Rectal
Surgery
13.6.1.2.6. Colorectal
Surgery
13.6.1.2.7. Brain
Mapping
13.6.1.2.8. Thyroid
Surgery
13.6.1.2.9. Ear,
Nose and Throat (ENT) Surgery
13.6.1.2.10. Others
13.6.1.3. France
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By End-User
13.6.1.3.1. Hospitals
13.6.1.3.2. Ambulatory
Surgical Centers
13.6.1.3.3. Others
13.6.1.4. France
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
13.6.1.4.1. Direct
13.6.1.4.2. Indirect
13.6.2. The UK
13.6.2.1. The
UK Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Component
13.6.2.1.1. Systems
13.6.2.1.2. Accessories
13.6.2.1.2.1. Stimulation
Probe
13.6.2.1.2.2. Tubes
13.6.2.1.2.3. Electrodes
13.6.2.1.2.4. Others
13.6.2.1.3. Services
13.6.2.2. The
UK Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Application
13.6.2.2.1. Neurosurgery
13.6.2.2.2. Spine
Surgery
13.6.2.2.3. Vascular
Surgery
13.6.2.2.4. Facial
Nerve Surgery
13.6.2.2.5. Rectal
Surgery
13.6.2.2.6. Colorectal
Surgery
13.6.2.2.7. Brain
Mapping
13.6.2.2.8. Thyroid
Surgery
13.6.2.2.9. Ear,
Nose and Throat (ENT) Surgery
13.6.2.2.10. Others
13.6.2.3. The
UK Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By End-User
13.6.2.3.1. Hospitals
13.6.2.3.2. Ambulatory
Surgical Centers
13.6.2.3.3. Others
13.6.2.4. The
UK Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
13.6.2.4.1. Direct
13.6.2.4.2. Indirect
13.6.3. Spain
13.6.3.1. Spain
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Component
13.6.3.1.1. Systems
13.6.3.1.2. Accessories
13.6.3.1.2.1. Stimulation
Probe
13.6.3.1.2.2. Tubes
13.6.3.1.2.3. Electrodes
13.6.3.1.2.4. Others
13.6.3.1.3. Services
13.6.3.2. Spain
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Application
13.6.3.2.1. Neurosurgery
13.6.3.2.2. Spine
Surgery
13.6.3.2.3. Vascular
Surgery
13.6.3.2.4. Facial
Nerve Surgery
13.6.3.2.5. Rectal
Surgery
13.6.3.2.6. Colorectal
Surgery
13.6.3.2.7. Brain
Mapping
13.6.3.2.8. Thyroid
Surgery
13.6.3.2.9. Ear,
Nose and Throat (ENT) Surgery
13.6.3.2.10. Others
13.6.3.3. Spain
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By End-User
13.6.3.3.1. Hospitals
13.6.3.3.2. Ambulatory
Surgical Centers
13.6.3.3.3. Others
13.6.3.4. Spain
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
13.6.3.4.1. Direct
13.6.3.4.2. Indirect
13.6.4. Germany
13.6.4.1. Germany
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Component
13.6.4.1.1. Systems
13.6.4.1.2. Accessories
13.6.4.1.2.1. Stimulation
Probe
13.6.4.1.2.2. Tubes
13.6.4.1.2.3. Electrodes
13.6.4.1.2.4. Others
13.6.4.1.3. Services
13.6.4.2. Germany
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Application
13.6.4.2.1. Neurosurgery
13.6.4.2.2. Spine
Surgery
13.6.4.2.3. Vascular
Surgery
13.6.4.2.4. Facial
Nerve Surgery
13.6.4.2.5. Rectal
Surgery
13.6.4.2.6. Colorectal
Surgery
13.6.4.2.7. Brain
Mapping
13.6.4.2.8. Thyroid
Surgery
13.6.4.2.9. Ear,
Nose and Throat (ENT) Surgery
13.6.4.2.10. Others
13.6.4.3. Germany
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By End-User
13.6.4.3.1. Hospitals
13.6.4.3.2. Ambulatory
Surgical Centers
13.6.4.3.3. Others
13.6.4.4. Germany
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
13.6.4.4.1. Direct
13.6.4.4.2. Indirect
13.6.5. Italy
13.6.5.1. Italy
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Component
13.6.5.1.1. Systems
13.6.5.1.2. Accessories
13.6.5.1.2.1. Stimulation
Probe
13.6.5.1.2.2. Tubes
13.6.5.1.2.3. Electrodes
13.6.5.1.2.4. Others
13.6.5.1.3. Services
13.6.5.2. Italy
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Application
13.6.5.2.1. Neurosurgery
13.6.5.2.2. Spine
Surgery
13.6.5.2.3. Vascular
Surgery
13.6.5.2.4. Facial
Nerve Surgery
13.6.5.2.5. Rectal
Surgery
13.6.5.2.6. Colorectal
Surgery
13.6.5.2.7. Brain
Mapping
13.6.5.2.8. Thyroid
Surgery
13.6.5.2.9. Ear,
Nose and Throat (ENT) Surgery
13.6.5.2.10. Others
13.6.5.3. Italy
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By End-User
13.6.5.3.1. Hospitals
13.6.5.3.2. Ambulatory
Surgical Centers
13.6.5.3.3. Others
13.6.5.4. Italy
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
13.6.5.4.1. Direct
13.6.5.4.2. Indirect
13.6.6. Nordic
Countries
13.6.6.1. Nordic
Countries Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Component
13.6.6.1.1. Systems
13.6.6.1.2. Accessories
13.6.6.1.2.1. Stimulation
Probe
13.6.6.1.2.2. Tubes
13.6.6.1.2.3. Electrodes
13.6.6.1.2.4. Others
13.6.6.1.3. Services
13.6.6.2. Nordic
Countries Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Application
13.6.6.2.1. Neurosurgery
13.6.6.2.2. Spine
Surgery
13.6.6.2.3. Vascular
Surgery
13.6.6.2.4. Facial
Nerve Surgery
13.6.6.2.5. Rectal
Surgery
13.6.6.2.6. Colorectal
Surgery
13.6.6.2.7. Brain
Mapping
13.6.6.2.8. Thyroid
Surgery
13.6.6.2.9. Ear,
Nose and Throat (ENT) Surgery
13.6.6.2.10. Others
13.6.6.3. Nordic
Countries Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
End-User
13.6.6.3.1. Hospitals
13.6.6.3.2. Ambulatory
Surgical Centers
13.6.6.3.3. Others
13.6.6.4. Nordic
Countries Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
13.6.6.4.1. Direct
13.6.6.4.2. Indirect
13.6.6.5. Nordic
Countries Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux
Union
13.6.7.1. Benelux
Union Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Component
13.6.7.1.1. Systems
13.6.7.1.2. Accessories
13.6.7.1.2.1. Stimulation
Probe
13.6.7.1.2.2. Tubes
13.6.7.1.2.3. Electrodes
13.6.7.1.2.4. Others
13.6.7.1.3. Services
13.6.7.2. Benelux
Union Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Application
13.6.7.2.1. Neurosurgery
13.6.7.2.2. Spine
Surgery
13.6.7.2.3. Vascular
Surgery
13.6.7.2.4. Facial
Nerve Surgery
13.6.7.2.5. Rectal
Surgery
13.6.7.2.6. Colorectal
Surgery
13.6.7.2.7. Brain
Mapping
13.6.7.2.8. Thyroid
Surgery
13.6.7.2.9. Ear,
Nose and Throat (ENT) Surgery
13.6.7.2.10. Others
13.6.7.3. Benelux
Union Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By End-User
13.6.7.3.1. Hospitals
13.6.7.3.2. Ambulatory
Surgical Centers
13.6.7.3.3. Others
13.6.7.4. Benelux
Union Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
13.6.7.4.1. Direct
13.6.7.4.2. Indirect
13.6.7.5. Benelux
Union Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The
Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of
Europe
13.6.8.1. Rest
of Europe Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Component
13.6.8.1.1. Systems
13.6.8.1.2. Accessories
13.6.8.1.2.1. Stimulation
Probe
13.6.8.1.2.2. Tubes
13.6.8.1.2.3. Electrodes
13.6.8.1.2.4. Others
13.6.8.1.3. Services
13.6.8.2. Rest
of Europe Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Application
13.6.8.2.1. Neurosurgery
13.6.8.2.2. Spine
Surgery
13.6.8.2.3. Vascular
Surgery
13.6.8.2.4. Facial
Nerve Surgery
13.6.8.2.5. Rectal
Surgery
13.6.8.2.6. Colorectal
Surgery
13.6.8.2.7. Brain
Mapping
13.6.8.2.8. Thyroid
Surgery
13.6.8.2.9. Ear,
Nose and Throat (ENT) Surgery
13.6.8.2.10. Others
13.6.8.3. Rest
of Europe Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
End-User
13.6.8.3.1. Hospitals
13.6.8.3.2. Ambulatory
Surgical Centers
13.6.8.3.3. Others
13.6.8.4. Rest
of Europe Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
13.6.8.4.1. Direct
13.6.8.4.2. Indirect
13.7. Key
Segment for Channeling Investments
13.7.1. By
Country
13.7.2. By
Component
13.7.3. By
Application
13.7.4. By
End-User
13.7.5. By
Distribution Channel
14. Asia
Pacific Neuromonitoring Devices Market Analysis and Forecasts, 2021 - 2029
14.1. Overview
14.1.1. Asia
Pacific Neuromonitoring Devices Market Revenue (US$ Mn)
14.2. Asia Pacific
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Component
14.2.1. Systems
14.2.2. Accessories
14.2.2.1. Stimulation
Probe
14.2.2.2. Tubes
14.2.2.3. Electrodes
14.2.2.4. Others
14.2.3. Services
14.3. Asia
Pacific Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Application
14.3.1. Neurosurgery
14.3.2. Spine
Surgery
14.3.3. Vascular
Surgery
14.3.4. Facial
Nerve Surgery
14.3.5. Rectal
Surgery
14.3.6. Colorectal
Surgery
14.3.7. Brain
Mapping
14.3.8. Thyroid
Surgery
14.3.9. Ear,
Nose and Throat (ENT) Surgery
14.3.10. Others
14.4. Asia
Pacific Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
End-User
14.4.1. Hospitals
14.4.2. Ambulatory
Surgical Centers
14.4.3. Others
14.5. Asia
Pacific Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
14.5.1. Direct
14.5.2. Indirect
14.6. Asia
Pacific Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Country
14.6.1. China
14.6.1.1. China
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Component
14.6.1.1.1. Systems
14.6.1.1.2. Accessories
14.6.1.1.2.1. Stimulation
Probe
14.6.1.1.2.2. Tubes
14.6.1.1.2.3. Electrodes
14.6.1.1.2.4. Others
14.6.1.1.3. Services
14.6.1.2. China
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Application
14.6.1.2.1. Neurosurgery
14.6.1.2.2. Spine
Surgery
14.6.1.2.3. Vascular
Surgery
14.6.1.2.4. Facial
Nerve Surgery
14.6.1.2.5. Rectal
Surgery
14.6.1.2.6. Colorectal
Surgery
14.6.1.2.7. Brain
Mapping
14.6.1.2.8. Thyroid
Surgery
14.6.1.2.9. Ear,
Nose and Throat (ENT) Surgery
14.6.1.2.10. Others
14.6.1.3. China
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By End-User
14.6.1.3.1. Hospitals
14.6.1.3.2. Ambulatory
Surgical Centers
14.6.1.3.3. Others
14.6.1.4. China
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.6.1.4.1. Direct
14.6.1.4.2. Indirect
14.6.2. Japan
14.6.2.1. Japan
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Component
14.6.2.1.1. Systems
14.6.2.1.2. Accessories
14.6.2.1.2.1. Stimulation
Probe
14.6.2.1.2.2. Tubes
14.6.2.1.2.3. Electrodes
14.6.2.1.2.4. Others
14.6.2.1.3. Services
14.6.2.2. Japan
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Application
14.6.2.2.1. Neurosurgery
14.6.2.2.2. Spine
Surgery
14.6.2.2.3. Vascular
Surgery
14.6.2.2.4. Facial
Nerve Surgery
14.6.2.2.5. Rectal
Surgery
14.6.2.2.6. Colorectal
Surgery
14.6.2.2.7. Brain
Mapping
14.6.2.2.8. Thyroid
Surgery
14.6.2.2.9. Ear,
Nose and Throat (ENT) Surgery
14.6.2.2.10. Others
14.6.2.3. Japan
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By End-User
14.6.2.3.1. Hospitals
14.6.2.3.2. Ambulatory
Surgical Centers
14.6.2.3.3. Others
14.6.2.4. Japan
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.6.2.4.1. Direct
14.6.2.4.2. Indirect
14.6.3. India
14.6.3.1. India
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Component
14.6.3.1.1. Systems
14.6.3.1.2. Accessories
14.6.3.1.2.1. Stimulation
Probe
14.6.3.1.2.2. Tubes
14.6.3.1.2.3. Electrodes
14.6.3.1.2.4. Others
14.6.3.1.3. Services
14.6.3.2. India
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Application
14.6.3.2.1. Neurosurgery
14.6.3.2.2. Spine
Surgery
14.6.3.2.3. Vascular
Surgery
14.6.3.2.4. Facial
Nerve Surgery
14.6.3.2.5. Rectal
Surgery
14.6.3.2.6. Colorectal
Surgery
14.6.3.2.7. Brain
Mapping
14.6.3.2.8. Thyroid
Surgery
14.6.3.2.9. Ear,
Nose and Throat (ENT) Surgery
14.6.3.2.10. Others
14.6.3.3. India
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By End-User
14.6.3.3.1. Hospitals
14.6.3.3.2. Ambulatory
Surgical Centers
14.6.3.3.3. Others
14.6.3.4. India
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.6.3.4.1. Direct
14.6.3.4.2. Indirect
14.6.4. New
Zealand
14.6.4.1. New
Zealand Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Component
14.6.4.1.1. Systems
14.6.4.1.2. Accessories
14.6.4.1.2.1. Stimulation
Probe
14.6.4.1.2.2. Tubes
14.6.4.1.2.3. Electrodes
14.6.4.1.2.4. Others
14.6.4.1.3. Services
14.6.4.2. New
Zealand Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Application
14.6.4.2.1. Neurosurgery
14.6.4.2.2. Spine
Surgery
14.6.4.2.3. Vascular
Surgery
14.6.4.2.4. Facial
Nerve Surgery
14.6.4.2.5. Rectal
Surgery
14.6.4.2.6. Colorectal
Surgery
14.6.4.2.7. Brain
Mapping
14.6.4.2.8. Thyroid
Surgery
14.6.4.2.9. Ear,
Nose and Throat (ENT) Surgery
14.6.4.2.10. Others
14.6.4.3. New
Zealand Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
End-User
14.6.4.3.1. Hospitals
14.6.4.3.2. Ambulatory
Surgical Centers
14.6.4.3.3. Others
14.6.4.4. New
Zealand Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
14.6.4.4.1. Direct
14.6.4.4.2. Indirect
14.6.5. Australia
14.6.5.1. Australia
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Component
14.6.5.1.1. Systems
14.6.5.1.2. Accessories
14.6.5.1.2.1. Stimulation
Probe
14.6.5.1.2.2. Tubes
14.6.5.1.2.3. Electrodes
14.6.5.1.2.4. Others
14.6.5.1.3. Services
14.6.5.2. Australia
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Application
14.6.5.2.1. Neurosurgery
14.6.5.2.2. Spine
Surgery
14.6.5.2.3. Vascular
Surgery
14.6.5.2.4. Facial
Nerve Surgery
14.6.5.2.5. Rectal
Surgery
14.6.5.2.6. Colorectal
Surgery
14.6.5.2.7. Brain
Mapping
14.6.5.2.8. Thyroid
Surgery
14.6.5.2.9. Ear,
Nose and Throat (ENT) Surgery
14.6.5.2.10. Others
14.6.5.3. Australia
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By End-User
14.6.5.3.1. Hospitals
14.6.5.3.2. Ambulatory
Surgical Centers
14.6.5.3.3. Others
14.6.5.4. Australia
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
14.6.5.4.1. Direct
14.6.5.4.2. Indirect
14.6.6. South
Korea
14.6.6.1. South
Korea Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Component
14.6.6.1.1. Systems
14.6.6.1.2. Accessories
14.6.6.1.2.1. Stimulation
Probe
14.6.6.1.2.2. Tubes
14.6.6.1.2.3. Electrodes
14.6.6.1.2.4. Others
14.6.6.1.3. Services
14.6.6.2. South
Korea Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Application
14.6.6.2.1. Neurosurgery
14.6.6.2.2. Spine
Surgery
14.6.6.2.3. Vascular
Surgery
14.6.6.2.4. Facial
Nerve Surgery
14.6.6.2.5. Rectal
Surgery
14.6.6.2.6. Colorectal
Surgery
14.6.6.2.7. Brain
Mapping
14.6.6.2.8. Thyroid
Surgery
14.6.6.2.9. Ear,
Nose and Throat (ENT) Surgery
14.6.6.2.10. Others
14.6.6.3. South
Korea Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By End-User
14.6.6.3.1. Hospitals
14.6.6.3.2. Ambulatory
Surgical Centers
14.6.6.3.3. Others
14.6.6.4. South
Korea Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
14.6.6.4.1. Direct
14.6.6.4.2. Indirect
14.6.7. Southeast
Asia
14.6.7.1. Southeast
Asia Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Component
14.6.7.1.1. Systems
14.6.7.1.2. Accessories
14.6.7.1.2.1. Stimulation
Probe
14.6.7.1.2.2. Tubes
14.6.7.1.2.3. Electrodes
14.6.7.1.2.4. Others
14.6.7.1.3. Services
14.6.7.2. Southeast
Asia Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Application
14.6.7.2.1. Neurosurgery
14.6.7.2.2. Spine
Surgery
14.6.7.2.3. Vascular
Surgery
14.6.7.2.4. Facial
Nerve Surgery
14.6.7.2.5. Rectal
Surgery
14.6.7.2.6. Colorectal
Surgery
14.6.7.2.7. Brain
Mapping
14.6.7.2.8. Thyroid
Surgery
14.6.7.2.9. Ear,
Nose and Throat (ENT) Surgery
14.6.7.2.10. Others
14.6.7.3. Southeast
Asia Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By End-User
14.6.7.3.1. Hospitals
14.6.7.3.2. Ambulatory
Surgical Centers
14.6.7.3.3. Others
14.6.7.4. Southeast
Asia Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
14.6.7.4.1. Direct
14.6.7.4.2. Indirect
14.6.7.5. Southeast
Asia Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest
of Southeast Asia
14.6.8. Rest of
Asia Pacific
14.6.8.1. Rest
of Asia Pacific Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts,
By Component
14.6.8.1.1. Systems
14.6.8.1.2. Accessories
14.6.8.1.2.1. Stimulation
Probe
14.6.8.1.2.2. Tubes
14.6.8.1.2.3. Electrodes
14.6.8.1.2.4. Others
14.6.8.1.3. Services
14.6.8.2. Rest
of Asia Pacific Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts,
By Application
14.6.8.2.1. Neurosurgery
14.6.8.2.2. Spine
Surgery
14.6.8.2.3. Vascular
Surgery
14.6.8.2.4. Facial
Nerve Surgery
14.6.8.2.5. Rectal
Surgery
14.6.8.2.6. Colorectal
Surgery
14.6.8.2.7. Brain
Mapping
14.6.8.2.8. Thyroid
Surgery
14.6.8.2.9. Ear,
Nose and Throat (ENT) Surgery
14.6.8.2.10. Others
14.6.8.3. Rest
of Asia Pacific Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts,
By End-User
14.6.8.3.1. Hospitals
14.6.8.3.2. Ambulatory
Surgical Centers
14.6.8.3.3. Others
14.6.8.4. Rest
of Asia Pacific Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
14.6.8.4.1. Direct
14.6.8.4.2. Indirect
14.7. Key
Segment for Channeling Investments
14.7.1. By
Country
14.7.2. By
Component
14.7.3. By
Application
14.7.4. By
End-User
14.7.5. By
Distribution Channel
15. Middle
East and Africa Neuromonitoring Devices Market Analysis and Forecasts, 2021 -
2029
15.1. Overview
15.1.1. Middle
East and Africa Neuromonitoring Devices Market Revenue (US$ Mn)
15.2. Middle
East and Africa Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts,
By Component
15.2.1. Systems
15.2.2. Accessories
15.2.2.1. Stimulation
Probe
15.2.2.2. Tubes
15.2.2.3. Electrodes
15.2.2.4. Others
15.2.3. Services
15.3. Middle
East and Africa Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts,
By Application
15.3.1. Neurosurgery
15.3.2. Spine
Surgery
15.3.3. Vascular
Surgery
15.3.4. Facial
Nerve Surgery
15.3.5. Rectal
Surgery
15.3.6. Colorectal
Surgery
15.3.7. Brain
Mapping
15.3.8. Thyroid
Surgery
15.3.9. Ear,
Nose and Throat (ENT) Surgery
15.3.10. Others
15.4. Middle
East and Africa Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts,
By End-User
15.4.1. Hospitals
15.4.2. Ambulatory
Surgical Centers
15.4.3. Others
15.5. Middle
East and Africa Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
15.5.1. Direct
15.5.2. Indirect
15.6. Middle
East and Africa Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts,
By Country
15.6.1. Saudi
Arabia
15.6.1.1. Saudi
Arabia Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Component
15.6.1.1.1. Systems
15.6.1.1.2. Accessories
15.6.1.1.2.1. Stimulation
Probe
15.6.1.1.2.2. Tubes
15.6.1.1.2.3. Electrodes
15.6.1.1.2.4. Others
15.6.1.1.3. Services
15.6.1.2. Saudi
Arabia Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Application
15.6.1.2.1. Neurosurgery
15.6.1.2.2. Spine
Surgery
15.6.1.2.3. Vascular
Surgery
15.6.1.2.4. Facial
Nerve Surgery
15.6.1.2.5. Rectal
Surgery
15.6.1.2.6. Colorectal
Surgery
15.6.1.2.7. Brain
Mapping
15.6.1.2.8. Thyroid
Surgery
15.6.1.2.9. Ear,
Nose and Throat (ENT) Surgery
15.6.1.2.10. Others
15.6.1.3. Saudi
Arabia Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
End-User
15.6.1.3.1. Hospitals
15.6.1.3.2. Ambulatory
Surgical Centers
15.6.1.3.3. Others
15.6.1.4. Saudi
Arabia Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.6.1.4.1. Direct
15.6.1.4.2. Indirect
15.6.2. UAE
15.6.2.1. UAE
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Component
15.6.2.1.1. Systems
15.6.2.1.2. Accessories
15.6.2.1.2.1. Stimulation
Probe
15.6.2.1.2.2. Tubes
15.6.2.1.2.3. Electrodes
15.6.2.1.2.4. Others
15.6.2.1.3. Services
15.6.2.2. UAE
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Application
15.6.2.2.1. Neurosurgery
15.6.2.2.2. Spine
Surgery
15.6.2.2.3. Vascular
Surgery
15.6.2.2.4. Facial
Nerve Surgery
15.6.2.2.5. Rectal
Surgery
15.6.2.2.6. Colorectal
Surgery
15.6.2.2.7. Brain
Mapping
15.6.2.2.8. Thyroid
Surgery
15.6.2.2.9. Ear,
Nose and Throat (ENT) Surgery
15.6.2.2.10. Others
15.6.2.3. UAE
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By End-User
15.6.2.3.1. Hospitals
15.6.2.3.2. Ambulatory
Surgical Centers
15.6.2.3.3. Others
15.6.2.4. UAE
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
15.6.2.4.1. Direct
15.6.2.4.2. Indirect
15.6.3. Egypt
15.6.3.1. Egypt
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Component
15.6.3.1.1. Systems
15.6.3.1.2. Accessories
15.6.3.1.2.1. Stimulation
Probe
15.6.3.1.2.2. Tubes
15.6.3.1.2.3. Electrodes
15.6.3.1.2.4. Others
15.6.3.1.3. Services
15.6.3.2. Egypt
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Application
15.6.3.2.1. Neurosurgery
15.6.3.2.2. Spine
Surgery
15.6.3.2.3. Vascular
Surgery
15.6.3.2.4. Facial
Nerve Surgery
15.6.3.2.5. Rectal
Surgery
15.6.3.2.6. Colorectal
Surgery
15.6.3.2.7. Brain
Mapping
15.6.3.2.8. Thyroid
Surgery
15.6.3.2.9. Ear,
Nose and Throat (ENT) Surgery
15.6.3.2.10. Others
15.6.3.3. Egypt
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By End-User
15.6.3.3.1. Hospitals
15.6.3.3.2. Ambulatory
Surgical Centers
15.6.3.3.3. Others
15.6.3.4. Egypt
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
15.6.3.4.1. Direct
15.6.3.4.2. Indirect
15.6.4. Kuwait
15.6.4.1. Kuwait
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Component
15.6.4.1.1. Systems
15.6.4.1.2. Accessories
15.6.4.1.2.1. Stimulation
Probe
15.6.4.1.2.2. Tubes
15.6.4.1.2.3. Electrodes
15.6.4.1.2.4. Others
15.6.4.1.3. Services
15.6.4.2. Kuwait
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Application
15.6.4.2.1. Neurosurgery
15.6.4.2.2. Spine
Surgery
15.6.4.2.3. Vascular
Surgery
15.6.4.2.4. Facial
Nerve Surgery
15.6.4.2.5. Rectal
Surgery
15.6.4.2.6. Colorectal
Surgery
15.6.4.2.7. Brain
Mapping
15.6.4.2.8. Thyroid
Surgery
15.6.4.2.9. Ear,
Nose and Throat (ENT) Surgery
15.6.4.2.10. Others
15.6.4.3. Kuwait
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By End-User
15.6.4.3.1. Hospitals
15.6.4.3.2. Ambulatory
Surgical Centers
15.6.4.3.3. Others
15.6.4.4. Kuwait
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
15.6.4.4.1. Direct
15.6.4.4.2. Indirect
15.6.5. South
Africa
15.6.5.1. South
Africa Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Component
15.6.5.1.1. Systems
15.6.5.1.2. Accessories
15.6.5.1.2.1. Stimulation
Probe
15.6.5.1.2.2. Tubes
15.6.5.1.2.3. Electrodes
15.6.5.1.2.4. Others
15.6.5.1.3. Services
15.6.5.2. South
Africa Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Application
15.6.5.2.1. Neurosurgery
15.6.5.2.2. Spine
Surgery
15.6.5.2.3. Vascular
Surgery
15.6.5.2.4. Facial
Nerve Surgery
15.6.5.2.5. Rectal
Surgery
15.6.5.2.6. Colorectal
Surgery
15.6.5.2.7. Brain
Mapping
15.6.5.2.8. Thyroid
Surgery
15.6.5.2.9. Ear,
Nose and Throat (ENT) Surgery
15.6.5.2.10. Others
15.6.5.3. South
Africa Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
End-User
15.6.5.3.1. Hospitals
15.6.5.3.2. Ambulatory
Surgical Centers
15.6.5.3.3. Others
15.6.5.4. South
Africa Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
15.6.5.4.1. Direct
15.6.5.4.2. Indirect
15.6.6. Rest of
Middle East & Africa
15.6.6.1. Rest
of Middle East & Africa Neuromonitoring Devices Market Revenue (US$ Mn) and
Forecasts, By Component
15.6.6.1.1. Systems
15.6.6.1.2. Accessories
15.6.6.1.2.1. Stimulation
Probe
15.6.6.1.2.2. Tubes
15.6.6.1.2.3. Electrodes
15.6.6.1.2.4. Others
15.6.6.1.3. Services
15.6.6.2. Rest
of Middle East & Africa Neuromonitoring Devices Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.6.2.1. Neurosurgery
15.6.6.2.2. Spine
Surgery
15.6.6.2.3. Vascular
Surgery
15.6.6.2.4. Facial
Nerve Surgery
15.6.6.2.5. Rectal
Surgery
15.6.6.2.6. Colorectal
Surgery
15.6.6.2.7. Brain
Mapping
15.6.6.2.8. Thyroid
Surgery
15.6.6.2.9. Ear,
Nose and Throat (ENT) Surgery
15.6.6.2.10. Others
15.6.6.3. Rest
of Middle East & Africa Neuromonitoring Devices Market Revenue (US$ Mn) and
Forecasts, By End-User
15.6.6.3.1. Hospitals
15.6.6.3.2. Ambulatory
Surgical Centers
15.6.6.3.3. Others
15.6.6.4. Rest
of Middle East & Africa Neuromonitoring Devices Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
15.6.6.4.1. Direct
15.6.6.4.2. Indirect
15.7. Key
Segment for Channeling Investments
15.7.1. By
Country
15.7.2. By
Component
15.7.3. By
Application
15.7.4. By
End-User
15.7.5. By
Distribution Channel
16. Latin
America Neuromonitoring Devices Market Analysis and Forecasts, 2021 - 2029
16.1. Overview
16.1.1. Latin
America Neuromonitoring Devices Market Revenue (US$ Mn)
16.2. Latin
America Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Component
16.2.1. Systems
16.2.2. Accessories
16.2.2.1. Stimulation
Probe
16.2.2.2. Tubes
16.2.2.3. Electrodes
16.2.2.4. Others
16.2.3. Services
16.3. Latin
America Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Application
16.3.1. Neurosurgery
16.3.2. Spine
Surgery
16.3.3. Vascular
Surgery
16.3.4. Facial
Nerve Surgery
16.3.5. Rectal
Surgery
16.3.6. Colorectal
Surgery
16.3.7. Brain
Mapping
16.3.8. Thyroid
Surgery
16.3.9. Ear,
Nose and Throat (ENT) Surgery
16.3.10. Others
16.4. Latin
America Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
End-User
16.4.1. Hospitals
16.4.2. Ambulatory
Surgical Centers
16.4.3. Others
16.5. Latin
America Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Distribution Channel
16.5.1. Direct
16.5.2. Indirect
16.6. Latin
America Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By
Country
16.6.1. Brazil
16.6.1.1. Brazil
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Component
16.6.1.1.1. Systems
16.6.1.1.2. Accessories
16.6.1.1.2.1. Stimulation
Probe
16.6.1.1.2.2. Tubes
16.6.1.1.2.3. Electrodes
16.6.1.1.2.4. Others
16.6.1.1.3. Services
16.6.1.2. Brazil
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Application
16.6.1.2.1. Neurosurgery
16.6.1.2.2. Spine
Surgery
16.6.1.2.3. Vascular
Surgery
16.6.1.2.4. Facial
Nerve Surgery
16.6.1.2.5. Rectal
Surgery
16.6.1.2.6. Colorectal
Surgery
16.6.1.2.7. Brain
Mapping
16.6.1.2.8. Thyroid
Surgery
16.6.1.2.9. Ear,
Nose and Throat (ENT) Surgery
16.6.1.2.10. Others
16.6.1.3. Brazil
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By End-User
16.6.1.3.1. Hospitals
16.6.1.3.2. Ambulatory
Surgical Centers
16.6.1.3.3. Others
16.6.1.4. Brazil
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
16.6.1.4.1. Direct
16.6.1.4.2. Indirect
16.6.2. Argentina
16.6.2.1. Argentina
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Component
16.6.2.1.1. Systems
16.6.2.1.2. Accessories
16.6.2.1.2.1. Stimulation
Probe
16.6.2.1.2.2. Tubes
16.6.2.1.2.3. Electrodes
16.6.2.1.2.4. Others
16.6.2.1.3. Services
16.6.2.2. Argentina
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Application
16.6.2.2.1. Neurosurgery
16.6.2.2.2. Spine
Surgery
16.6.2.2.3. Vascular
Surgery
16.6.2.2.4. Facial
Nerve Surgery
16.6.2.2.5. Rectal
Surgery
16.6.2.2.6. Colorectal
Surgery
16.6.2.2.7. Brain
Mapping
16.6.2.2.8. Thyroid
Surgery
16.6.2.2.9. Ear,
Nose and Throat (ENT) Surgery
16.6.2.2.10. Others
16.6.2.3. Argentina
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By End-User
16.6.2.3.1. Hospitals
16.6.2.3.2. Ambulatory
Surgical Centers
16.6.2.3.3. Others
16.6.2.4. Argentina
Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts, By Distribution
Channel
16.6.2.4.1. Direct
16.6.2.4.2. Indirect
16.6.3. Rest of
Latin America
16.6.3.1. Rest
of Latin America Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts,
By Component
16.6.3.1.1. Systems
16.6.3.1.2. Accessories
16.6.3.1.2.1. Stimulation
Probe
16.6.3.1.2.2. Tubes
16.6.3.1.2.3. Electrodes
16.6.3.1.2.4. Others
16.6.3.1.3. Services
16.6.3.2. Rest
of Latin America Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts,
By Application
16.6.3.2.1. Neurosurgery
16.6.3.2.2. Spine
Surgery
16.6.3.2.3. Vascular
Surgery
16.6.3.2.4. Facial
Nerve Surgery
16.6.3.2.5. Rectal
Surgery
16.6.3.2.6. Colorectal
Surgery
16.6.3.2.7. Brain
Mapping
16.6.3.2.8. Thyroid
Surgery
16.6.3.2.9. Ear,
Nose and Throat (ENT) Surgery
16.6.3.2.10. Others
16.6.3.3. Rest
of Latin America Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts,
By End-User
16.6.3.3.1. Hospitals
16.6.3.3.2. Ambulatory
Surgical Centers
16.6.3.3.3. Others
16.6.3.4. Rest
of Latin America Neuromonitoring Devices Market Revenue (US$ Mn) and Forecasts,
By Distribution Channel
16.6.3.4.1. Direct
16.6.3.4.2. Indirect
16.7. Key
Segment for Channeling Investments
16.7.1. By
Country
16.7.2. By
Component
16.7.3. By
Application
16.7.4. By
End-User
16.7.5. By
Distribution Channel
17. Competitive
Benchmarking
17.1. Market
Share Analysis, 2020
17.2. Global
Presence and Growth Strategies
17.2.1. Mergers
and Acquisitions
17.2.2. Product
Launches
17.2.3. Investments
Trends
17.2.4. R&D
Initiatives
18. Player
Profiles
18.1. Cadwell
Industries Inc
18.1.1. Company
Details
18.1.2. Company
Overview
18.1.3. Product
Offerings
18.1.4. Key
Developments
18.1.5. Financial
Analysis
18.1.6. SWOT
Analysis
18.1.7. Business
Strategies
18.2. inomed
Medizintechnik GmbH
18.2.1. Company
Details
18.2.2. Company
Overview
18.2.3. Product
Offerings
18.2.4. Key
Developments
18.2.5. Financial
Analysis
18.2.6. SWOT
Analysis
18.2.7. Business
Strategies
18.3. Integra
Life Sciences
18.3.1. Company
Details
18.3.2. Company
Overview
18.3.3. Product
Offerings
18.3.4. Key
Developments
18.3.5. Financial
Analysis
18.3.6. SWOT
Analysis
18.3.7. Business
Strategies
18.4. Medtronic
18.4.1. Company
Details
18.4.2. Company
Overview
18.4.3. Product
Offerings
18.4.4. Key
Developments
18.4.5. Financial
Analysis
18.4.6. SWOT
Analysis
18.4.7. Business
Strategies
18.5. Moberg
Research, Inc
18.5.1. Company
Details
18.5.2. Company
Overview
18.5.3. Product
Offerings
18.5.4. Key
Developments
18.5.5. Financial
Analysis
18.5.6. SWOT
Analysis
18.5.7. Business
Strategies
18.6. Natus
Medical
18.6.1. Company
Details
18.6.2. Company
Overview
18.6.3. Product
Offerings
18.6.4. Key
Developments
18.6.5. Financial
Analysis
18.6.6. SWOT
Analysis
18.6.7. Business
Strategies
18.7. Neurosoft
18.7.1. Company
Details
18.7.2. Company
Overview
18.7.3. Product
Offerings
18.7.4. Key
Developments
18.7.5. Financial
Analysis
18.7.6. SWOT
Analysis
18.7.7. Business
Strategies
18.8. Neurostyle
18.8.1. Company
Details
18.8.2. Company
Overview
18.8.3. Product
Offerings
18.8.4. Key
Developments
18.8.5. Financial
Analysis
18.8.6. SWOT
Analysis
18.8.7. Business
Strategies
18.9. Neurovision
Medical Products
18.9.1. Company
Details
18.9.2. Company
Overview
18.9.3. Product
Offerings
18.9.4. Key
Developments
18.9.5. Financial
Analysis
18.9.6. SWOT
Analysis
18.9.7. Business
Strategies
18.10. Nihon
Kohden Corporation
18.10.1. Company
Details
18.10.2. Company
Overview
18.10.3. Product
Offerings
18.10.4. Key
Developments
18.10.5. Financial
Analysis
18.10.6. SWOT Analysis
18.10.7. Business
Strategies
18.11. Other
Market Participants
19. Key
Findings
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.